Event Abstract Back to Event Trehalose glycopolymer hydrogels and conjugates for protein stabilization Heather Maynard1 1 UCLA, Chemistry and Biochemistry, United States Introduction: Therapeutic proteins are challenging to transport and store and the majority need to be refrigerated or frozen. Proteins exposed to these stressors often lose activity. This can be harmful or even fatal for patients that take the medicines. Thus polymers and hydrogels that are capable of stabilizing biomolecules at room temperature are of significant interest. The disaccharide sugar, trehalose, is known to stabilize proteins to a variety of environments including to elevated temperatures and desiccation. We hypothesized that by preparing polymers with side chain trehalose units, the resulting materials would also stabilize proteins. This talk will focus on linear polymer conjugates and hydrogels with trehalose as a component for protein stabilization. Results and Discussion: A library of polymers with polystyrene or polymethacrylate backbones and trehalose side chains was prepared by free radical polymerization. Therapeutic proteins such as insulin were tested under stress conditions such as heat with and without added polymer. The polymers that performed optimally in this exercise were utilized to prepare conjugates with the therapeutic proteins. This was accomplished by synthesizing the polymers by reversible addition-fragmentation chain transfer (RAFT) polymerization utilizing functional chain transfer agents (CTA) so that the resulting polymers contained end groups reactive to amino acid side chains on proteins. The polymers were then conjugated to the proteins and the resulting conjugates purified by fast protein liquid chromatography. Pharmacokinetics in mice, in vitro and in vivo bioactivity, and stability to elevated temperatures were evaluated. The results showed that the trehalose polymers were able to (a) enhance the plasma half life similar to gold standard poly(ethylene glycol) (PEG), (b) remain bioactive similar to the analogous PEGylated proteins, and (c) stabilize the proteins to elevated temperatures. They were also non-toxic in vitro and in vivo. Discussion of this research will encompass the first part of the talk. Hydrogels were also prepared by either free radical polymerization of the trehalose monomers and trehalose crosslinkers or by specific condensation reactions between the trehalose polymers and boronic acid end-functionalized PEGs. Both cases resulted in gels that could incorporate and stabilize proteins such as insulin to thermal stress. The gels released the proteins by passive release or by triggered release by glucose, respectively. This research will be discussed in the second part of this talk. Conclusions: Trehalose materials, also called PolyProtek, are excellent protein stabilizers. Make in a linear form, the polymers form therapeutic protein conjugates that are bioactive and stable to temperatures and in vivo. As a hydrogel the materials can stabilize prior to triggered release of proteins. Thus, trehalose materials are promising for therapeutic applications. National Science Foundation (grants CHE-1112550 and CHE-1507735) Keywords: Hydrogel, Drug delivery, Bioactivity, Polymeric material Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: New Frontier Oral Topic: Nano-structured materials for unique functions Citation: Maynard H (2016). Trehalose glycopolymer hydrogels and conjugates for protein stabilization. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01532 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Heather Maynard Google Heather Maynard Google Scholar Heather Maynard PubMed Heather Maynard Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.
Read full abstract